Illumina

Senior Territory Account Manager - Healthcare

Ohio, United States

Apply now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Genomics, Life SciencesIndustries

Requirements

Candidates must possess a Bachelor's degree in a related field, along with 5 years or more of life science capital sales experience, and a foundational understanding of next generation sequencing (NGS) and genotyping. Demonstrated experience working with key clinical and research accounts and customers in Ohio, coupled with success in consultative and strategic selling situations, is required.

Responsibilities

The Senior Territory Account Manager will develop and implement sales plans to achieve territory sales objectives and growth targets, accurately forecast sales projections, proactively utilize and maintain a CRM database, deliver technical/scientific seminars and presentations on Illumina products/solutions, demonstrate the role and relevance of the product portfolio, and engage in collaborative and consultative sales processes to drive complex sales within multi-layered environments.

Skills

Genomics

Next Generation Sequencing (NGS)

Genotyping

Sales Planning

Customer Engagement

CRM Management

Consultative Selling

Strategic Selling

Business Development

Account Management

Market Analysis

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free